Amgen
Top View
- CB2013 Committee and Board Disclosureauditlist 6.20.13
- In Their Words
- Amgen Brochure
- TRUEBLUE TRUEBLUE SNAPSHOT Who We Are
- Can Vaccine Development Be Safely Accelerated?
- Makers Took Big Price Increases on Widely Used U.S
- 1 in the United States District Court for the District Of
- Gilead Sciences Appoints Flavius Martin, MD As Executive Vice President, Research
- Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
- Amgen and Abbvie Agree to Settlement Allowing Commercialization of AMGEVITA ™
- Amgen Inc. (Exact Name of Registrant As Specified in Its Charter)
- Managing Costs and Care with Biosimilars
- Exhibit Guide Header
- Why Is Moderna Still So Pricey?
- Biogen Idec's Agenda
- Amgen V. Sanofi
- Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma
- EPO: Taking Some Comfort Johnson & Johnson